SCLC
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
SCLC
Oct 20, 2024, 11:34 |
Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Oct 17, 2024, 15:52 |
Blog
Oncology Brothers: Last 4 weeks in Lung Cancer
Oncology Brothers shared a post on X: "Last 4 weeks in Lung Cancer: 1. PR:…
Oct 17, 2024, 14:23 |
Blog
Register now for MAP 2024 - ESMO
The European Society for Medical Oncology (ESMO) made the following post on X: "Register now for…
Oct 17, 2024, 13:44 |
Blog
Ilya Nechaev: Is it a new milestone for SCLC patients?
Ilya Nechaev, Head of Medical Affairs at BostonGene, posted on LinkedIn: "Is it a new…
Oct 17, 2024, 12:57 |
Insight
Antonio Calles: Massive news for patients with SCLC
Antonio Calles, Medical Specialist in Medical Oncology at Gregorio Marañón General University Hospital, shared a…
Oct 15, 2024, 17:29 |
Blog
Jill Feldman: Interesting finding for people with EFGR lung cancer that transforms to SCLC
Jill Feldman shared a post on X by Stephen V Liu adding: "Very interesting finding…
Oct 14, 2024, 13:40 |
Insight
Retrospective report on EGFR mutant NSCLC transformed to SCLC, suggested by Stephen V Liu
Stephen V Liu shared a post on X: "Retrospective report in European Journal of Cancer on…
Oct 12, 2024, 22:16 |
Insight
Triparna Sen: CD38-mediated immunosuppression as a potential mechanism of tumor cell escape from PDL1 inhibition in SCLC
Triparna Sen, Associate Professor, Icahn School of Medicine at Mount Sinai, shared a post on…
Oct 11, 2024, 13:45 |
Blog
Triparna Sen: DDR protein ATR activation enhances immunotherapy in SCLC
Triparna Sen posted the following on X: “Thank you Icahn School of Medicine at Mount…
Oct 6, 2024, 16:44 |
Insight
Amrubicin + irinotecan vs cisplatin + irinotecan for SCLC
Stephen V Liu shared a post on X: "Randomized phase II: 1L amrubicin + irinotecan vs…
Oct 6, 2024, 13:47 |
Blog
Ana I. Velázquez Mañana: Lung Cancer management updates from 2024 by Weill Cornell Medicine Meyer Cancer Center
Ana I. Velázquez Mañana shared a post on X: ''Christine Garcia from Weill Cornell Medicine…
Oct 6, 2024, 12:22 |
Insight
Stephen V Liu: Randomized phase II trial results on amrubicin vs cisplatin for SCLC
Stephen V Liu posted the following on X: “Randomized phase II: 1L amrubicin + irinotecan…
Oct 5, 2024, 13:57 |
Blog
The importance of clinical trials and the role of translational research in SCLC - LUNGevity Foundation
LUNGevity Foundation shared a post on X: "Our next Small Cell SMASHERS Fireside Chat with Christine…
Oct 5, 2024, 12:11 |
Blog
Biagio Ricciuti: Stephen Liu on the evolving treatment landscape for SCLC
Biagio Ricciuti shared a post on X: "Comprehensive overview of the evolving treatment landscape for…
Sep 19, 2024, 08:35 |
Insight
Iván R. González: Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
Iván R. González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared on X:…
Sep 18, 2024, 14:28 |
Blog
Aakash Desai: Proteomic Characterization of ADC Target Expression Profiles in SCLC
Aakash Desai, Assistant Professor at UAB O'Neal Comprehensive Cancer Center, shared a post on LinkedIn:…
Sep 15, 2024, 16:26 |
Societies
43 Posts Not To Miss From ESMO24 Day 2
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 10, 2024, 16:09 |
Societies
Highlights from WCLC24 by Stephen V Liu Part 2
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 9, 2024, 11:35 |
Societies
Inside WCLC24 - Recap by Estela Rodriguez
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 9, 2024, 11:25 |
Insight
Amol Akhade: I-DXD shows promising activity in heavily pretreated Extensive stage SCLC
Amol Akhade shared on LinkedIn: “I-DXD ( Ifinatamab Deruxtecan) shows promising activity in heavily pretreated…
Aug 31, 2024, 20:07 |
Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 29, 2024, 17:26 |
Blog
Natasha Rekhtman: Chromothripsis-mediated Small Cell Lung Cancer
Natasha Rekhtman posted on X: "Hot off the press from team Memorial Sloan Kettering Cancer…
Aug 26, 2024, 20:32 |
Blog
Nagla Abdel Karim: Presenting updates in SCLC at ASCO Direct
Nagla Abdel Karim, Associate Professor of Medicine-Division of Hematology/Oncology at the University of Cincinnati, shared…
Aug 22, 2024, 16:31 |
Insight
Applications for ESMO Preceptorship on NSCLC and SCLC are open
ESMO – European Society for Medical Oncology shared on LinkedIn: “ESMO Preceptorship on NSCLC and…
Aug 22, 2024, 10:44 |
Blog
Misty Dawn Shields: Truly proud in the Shields Lab and the work being done in the fight against SCLC
Misty Dawn Shields, Translational Thoracic Oncologist at The Shields Lab and Asst Professor at Indiana University,…
Aug 16, 2024, 14:13 |
Insight
OS rates for IMpower133 and IMbrella A extension study in SCLC
Biagio Ricciuti shared a paper by Martin Reck et al. on X, adding: “Five-year survival…
Aug 14, 2024, 13:00 |
Insight
Aditya Juloori: Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer
Aditya Juloori, Radiation Oncologist at The University of Chicago Medical Center, shared on X: "Check…
Aug 14, 2024, 07:04 |
Insight
ES-SCLC 5-year survival outcomes inIMpower133 and IMbrella study
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X, about recent paper…
Aug 9, 2024, 12:23 |
Blog
The 6th International Lung Cancer Summit
The 6th International Lung Cancer Summit is a hybrid conference that will be held at…
Jul 25, 2024, 06:32 |
Insight
Stephen Liu: Novel epigenomic cfDNA approach in diagnosis of EGFR mutant NSCLC
Stephen Liu shared a post on X about a recent paper by Jacob E. Berchuck…
Jul 25, 2024, 00:12 |
Opinion
Giannis Mountzios: A fascinating update on SCLC by Triparna Sen et al.
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital,…
Jul 18, 2024, 09:54 |
Blog
Aman Chauhan: Honored to round with these exceptional Fellows and Residents
Aman Chauhan shared a post on X: . "Honored to round with the exceptional Sylvester…
Jul 3, 2024, 14:37 |
Insight
Jarushka Naidoo: Phase III RESILIENT Trial of Liposomal Irinotecan v Topotecan in 2L SCLC
Jarushka Naidoo shared a post on X: “Phase III RESILIENT Trial of Liposomal Irinotecan v…
Jun 21, 2024, 13:54 |
Insight
Real world eligibility for clinical trials in ES-SCLC
Stephen Liu shared on X/Twitter: "We know that clinical trials represent an idealized population. Illustrated by…
Jun 18, 2024, 06:26 |
Blog
Chul Kim: Dr. Jacob Zaemes, BIDMC is lucky to have you
Chul Kim shared on X: "Big congrats to my mentee, Dr. Jacob Zaemes, on his…
Jun 14, 2024, 16:23 |
Societies
ASCO issued a rapid guideline update on systemic therapy for SCLC
ASCO shared on X: "We’ve issued a rapid guideline update on systemic therapy for SCLC.…
Jun 8, 2024, 16:06 |
Blog
Reflections on ASCO24 by Jill Feldman
Jill Feldman shared on X/Twitter: "1. What an honor to meet Dr. Lynn Schuchter. I'm grateful…
Jun 3, 2024, 15:25 |
Societies
15 Posts From ASCO24 Day 3 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
May 31, 2024, 07:45 |
Insight
Aakash Desai: ASCO24 set to showcase some SCLC research, hopefully pushing boundaries in this field
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared on LinkedIn: “T-2 ASCO24…
May 20, 2024, 14:10 |
Blog
Analysis of SCLC transcriptional factor subtypes finds differential CNS-specific outcomes - Memorial Sloan Kettering Radiation Oncology
Memorial Sloan Kettering Radiation Oncology made the following post on X: New by Dr. Kathryn…
May 19, 2024, 10:55 |
Insight
Dhruba Deb: The 8 SCLC projects Lung Cancer Research Foundation recently funded
Dhruba Deb, Senior Director of Research and Administration at Lung Cancer Research Foundation, shared on…
May 18, 2024, 02:46 |
Drugs
Vivek Subbiah: US FDA granted accelerated approval to tarlatamab-dlle
Vivek Subbiah shared on X: "New FDA Approval. Today the US FDA granted accelerated approval…
May 12, 2024, 03:12 |
Blog
Misty Dawn Shields: Groundbreaking study challenging the dogma of 'YAP1' neuroendocrine subtype in SCLC
Misty Dawn Shields, Assistant Professor of Clinical Medicine, Division of Hematology/Oncology at IU School of…
May 9, 2024, 14:13 |
Insight
Jarushka Naidoo: Interesting multi-omic analysis of previously classified SCLC cell lines
Jarushka Naidoo shared a post on X: “Interesting multi-omic analysis of previously classified Small Cell Lung…
May 2, 2024, 15:25 |
Blog
Tanja Obradovic: Interesting updates will be coming on ASCO 2024
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: "ASCO 2024 is almost…
Apr 27, 2024, 10:46 |
Blog
Drew Moghanaki: Our residents at UCLA experienced a truly engaging lecture about SCLC by Jie Deng
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared on X/Twitter: "Our residents…
Apr 25, 2024, 12:40 |
Drugs
Piotr Wysocki: Similar activity of topotecan and liposomal irinotecan in second-line treatment of SCLC
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 9, 2024, 09:26 |
Blog
Misty Dawn Shields: Thank you to the Indiana University Graduate School Bloomington Medical Molecular Genetics program for the invitation to speak at the seminar series on Shields Lab research
Apr 8, 2024, 16:20 |
Drugs
Rami Manochakian: BIG NEWS press release by AstraZeneca!
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: “Hot Off…
Apr 2, 2024, 05:10 |
Blog
Chul Kim: March has been fruitful and rewarding, as we launched two IITs of ADC back to back!
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared on X/Twitter: "March has been fruitful…
Mar 11, 2024, 03:11 |
Blog
Herbert Loong: A privilege to participate and co-chair an informative event held at Amgen Oncology in Kuala Lumpur
Herbert Loong, Clinical Associate Professor at the Chinese University of Hong Kong, shared on X/Twitter:…
Feb 26, 2024, 11:16 |
Insight
Henry Rodriguez: Unraveling the mysteries of small cell lung cancer
Henry Rodriguez, Founding Director of the Office of Cancer Clinical Proteomics Research at the NCI,…
Jan 8, 2024, 14:29 |
Blog
Stephen V Liu: I discuss managing relapsed Small-Cell Lung Cancer with Fiona Blackhall and Misty Dawn Shields
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at the Lombardi Comprehensive Cancer…
Oct 20, 2023, 20:13 |
Insight
Aman Chauhan: We will continue to work on NEC and SCLC and hopefully find a breakthrough
Aman Chauhan, Leader of Neuroendocrine Cancer Program at the Sylvester Comprehensive Cancer Center, shared on his…
Aug 19, 2023, 16:22 |
Blog
Aman Chauhan: What an honor to interact with smart Oncologists from Brazil.
Quoting Aman Chauhan, an Assistant Professor of Medicine and the Director of the Neuroendocrine Cancer…
All:
55
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube